Hawaii 2022 Regular Session

Hawaii House Bill HB1037

Introduced
1/27/21  

Caption

Relating To The Electronic Prescription Accountability System.

Impact

One significant impact of this bill is its potential to streamline the process of managing prescriptions for controlled substances. By explicitly allowing various agencies and medical professionals access to relevant prescription data, the bill could facilitate better coordination in healthcare, assist in combating prescription drug abuse, and support law enforcement efforts in investigating misuse or criminal activities related to prescription medications.

Summary

House Bill 1037, titled 'Relating to the Electronic Prescription Accountability System,' proposes amendments to Section 329-104 of the Hawaii Revised Statutes. The bill aims to enhance the electronic prescription system by clarifying the entities and individuals authorized to access information stored within this system. This includes law enforcement officials, registered medical prescribers, and pharmacists, ensuring that patient information is shared responsibly and securely for the purposes of legal investigations or medical care.

Contention

Notable contention surrounding HB 1037 includes concerns about patient privacy and data security. While the bill outlines who may access prescription information, there may be apprehension regarding how safely that information is handled and the potential for misuse. Critics may argue that expanded access could compromise patient confidentiality, especially if adequate protections are not in place to safeguard sensitive health information. Additionally, discussions might arise regarding the balance between effective law enforcement and preserving individual privacy rights.

Companion Bills

HI SB1191

Same As Relating To The Electronic Prescription Accountability System.

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

TX SB1233

Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

LA HB548

Requires that the prescribers transmit prescriptions for opioids to pharmacies electronically (EG SEE FISC NOTE SG EX See Note)